The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes. - Test2 - elhamkhani - TriplyDB

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

http://www.wikidata.org/entity/Q37283747

about

Advances in HIV microbicide development Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells Targeting Trojan Horse leukocytes for HIV prevention.

P2860

Q26852858-E33F386B-3A00-4C40-A8B2-0F7B34E6386E Q30493649-C424433C-DC25-43A8-B915-883BA8AC233B Q30498853-6F1998D0-F9E7-411C-BD26-1C644620BB6C Q33518390-5E7E17E1-4ED7-4FCE-8C50-E0C0CDD5843A

P2860

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

http://www.wikidata.org/entity/Q37283747

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

@en

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

@nl

type

label

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

@en

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

@nl

prefLabel

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

@en

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.

@nl

P1433

Q37283747-CDE8016F-BEAC-4EE0-83AC-7240ED20BA94

P1476

Q37283747-7BB5D6E4-4A66-4E18-A909-97414DDB2E9E

P2093

Q37283747-296E2185-A615-4643-89F1-3AAC1E3FC3A3

Q37283747-91BE8226-59B6-4119-ADE6-F1C5193AA549

Q37283747-AB866412-9B0A-4C84-A775-EBE1FBAA16DA

Q37283747-C94CE771-CC2D-4AB0-AF27-8D26DB8961C3

Q37283747-C9AC8097-1A5E-46B4-B9FE-76259D7F9E66

Q37283747-F30B2741-1F82-446D-AB0B-1FEEC9D37FAB

P2860

Q37283747-05E8ABF5-7B4F-4B1B-9950-265DA5D5FCF2

Q37283747-1234F93B-127C-4138-A869-7802EA7EB7BD

Q37283747-2C024D7B-1644-41B8-9948-89BD28E2EA2F

Q37283747-2F1BB428-BD8B-45FC-975E-CC22FF308858

Q37283747-37C1E54E-09D1-4AD8-8DA4-30442C475DA1

Q37283747-443510A8-D87F-4CAF-965A-9FA72CF7E58D

Q37283747-454254BC-3612-4EEB-A7A5-8DA3CD4B130A

Q37283747-5BECE8E0-E385-4319-8AC2-07BB8D92CA76

Q37283747-6BBC7036-7D2F-4983-9F9E-A89EE5523822

Q37283747-6DD4170A-8474-4D7D-BC75-B4CB85409D4C

P304

Q37283747-5D0D254B-D73A-4029-AA8A-B8A22846573E

P31

Q37283747-FCF92145-E342-4C2A-9865-9D0E63E021BF

P356

Q37283747-1D4C721C-A77B-4373-86E0-7F4A9647666B

P407

Q37283747-E5AA1C69-C1AC-41BD-8D2D-C50EDE045D55

P433

Q37283747-2FF20CDF-4ADC-4124-9C35-6BA9F65E0202

P478

Q37283747-661400F9-CD19-4FF8-9715-544723A2C868

P50

Q37283747-DF0CAD8C-46A9-4D3E-89C2-8EAA7ED9D2AD

P577

Q37283747-22762922-C786-428D-AA67-87C7D1E67709

P698

Q37283747-4616A57A-970F-4DF5-8FBE-AC919203C17C

P932

Q37283747-94B43E80-FFD9-47DB-98A3-00FF5979F9B0

P356

QAI.0B013E31819F9E31

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes

@en

P2093

Albert T Profy

http://www.w3.org/2001/XMLSchema#string

Bouchra Zerhouni-Layachi

http://www.w3.org/2001/XMLSchema#string

Catarina E Hioe

http://www.w3.org/2001/XMLSchema#string

Darpun D Sachdev

http://www.w3.org/2001/XMLSchema#string

Mary E Klotman

http://www.w3.org/2001/XMLSchema#string

Michael Tuen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity

Molecular architecture of native HIV-1 gp120 trimers

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants.

Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya.

Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action.

Enhancement of HIV infection by cellulose sulfate.

P304

125-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E31819F9E31

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Mila B Ortigoza

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19349871

http://www.w3.org/2001/XMLSchema#string

P932

2718789

http://www.w3.org/2001/XMLSchema#string